Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 4 Stomach Neoplasms 2 Stomach Ulcer 1 Obesity 1 Gastritis 1 Dyspepsia 1 Adenocarcinoma of Lung 1

Interventions

Carboplatin 69 Paclitaxel 47 Radiotherapy 44 Pemetrexed 42 Cisplatin 41 Bevacizumab 36 Gemcitabine 27 Docetaxel 27 Erlotinib Hydrochloride 23 Gefitinib 18 pembrolizumab 14 Taxes 13 Vinorelbine 10 Cetuximab 10 Radiation 8 Nivolumab 8 Magnetic Resonance Spectroscopy 8 Radiosurgery 7 Platinum 7 Etoposide 7 Surgical Procedures, Operative 6 Radiotherapy, Conformal 6 ceritinib 5 capmatinib 5 aflutinib 5 Specimen Handling 5 Neoadjuvant Therapy 5 Mastectomy, Segmental 5 Cyclophosphamide 5 tislelizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Adenocarcinoma of Lung × Berberine × Clear all

NCT03486496 2018-04-03

Geber

Fujian Cancer Hospital

Phase 2 Unknown

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡